Crossmark

Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata

Crossref DOI link: https://doi.org/10.1186/s13287-018-0889-y

Published Online: 2018-05-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anderi, Rami

Makdissy, Nehman https://orcid.org/0000-0001-7240-0968
Azar, Albert

Rizk, Francine

Hamade, Aline
License Information

Text and Data Mining valid from 2018-05-15
More Information

Article History

Received: 21 February 2018

Revised: 23 April 2018

Accepted: 25 April 2018

First Online: 15 May 2018

Ethics approval and consent to participate

: The study was conducted in strict adherence to the tenets of the Declaration of Helsinki, and it was retrospectively registered in ClinicalTrials.gov (Identifier: NCT03427905). The protocol was approved by the institutional review board of REVIVA Regenerative Medicine Center at the Middle East Institute of Health University Hospital as previously [,] under the academic regulations of the public institution, the Lebanese University. All patients provided written informed consent and fresh samples were procured by Dr. Rami Andari (plastic surgeon) from REVIVA at the Middle East Institute of Health (MEIH) University Hospital. The first patient was enrolled in March 2013.

: The authors declare that they have no competing interests related to this study.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.